Argenta/Novartis Sign Two-Year Drug Discovery Pact
Argenta Discovery Ltd, Harlow, UK, a contract drug discovery and respiratory drug deve…
Category: Worldwide Biotech
Nanosphere/Takaro Bio Form Develop/Distribute Alliance
Nanosphere, Inc., Northbrook, Ill., a privately held nanotechnology-based life sci…
454 Life Sciences Gets Genome License From Pyrosequencing
454 Life Sciences, an innovative developer of genome-scale sequencing technolog…
Avidex Appoints Ultrafine To Develop/Manufacture Rhudex
Avidex Ltd., Oxford, UK, has appointed Ultrafine (UFC Ltd., Manchester, UK), to p…
Sloan Cancer Vaccine Phase Iii Study Begins
Merck KGaA, Darmstadt, Germany, has announced that the first patient has been enrolled in its…
Cryptome Gets Option For Anti-Inflammatory Drug License
Cryptome Pharmaceuticals Ltd, Melbourne, Australia, (ASX:CRP) has signed an agree…
Cyclacel Reports Progress With 2nd Generation Cdk Inhibitor
Cyclacel Limited, a UK-based biopharmaceutical company, has announced progres…
Astellas’ Screening Triggers Milestone Payment To Metabolex
Metabolex, Inc., Hayward, Calif., a biotechnology company dedicated to the di…
Surfaxin Gets Orphan Drug Designation From Emea
Discovery Laboratories, Inc. (Nasdaq:DSCO), Doylestown, Pa. has announced that the Commis…
Reminyl Alzheimer’s Treatment Gets First Eu Approval
REMINYL (galantamine), a new symptomatic treatment for dementia of the Alzheimer’s t…